Shanghai Rightongene Biotechnology Co., Ltd. (SHA:688217)

China flag China · Delayed Price · Currency is CNY
31.11
-0.15 (-0.48%)
At close: Feb 13, 2026
Market Cap1.72B +58.8%
Revenue (ttm)191.78M -23.0%
Net Income-27.11M
EPS-0.49
Shares Out55.19M
PE Ration/a
Forward PE124.44
Dividend0.34 (1.09%)
Ex-Dividend DateOct 24, 2025
Volume391,488
Average Volume901,663
Open31.36
Previous Close31.26
Day's Range31.03 - 31.64
52-Week Range17.50 - 36.00
Beta0.36
RSI56.91
Earnings DateApr 11, 2026

About SHA:688217

Shanghai Rightongene Biotechnology Co., Ltd. engages in the research and development, production, and sale of molecular diagnosis of infectious diseases in China. The company offers self-operated reagents, purchased preparations, scientific research services, and testing services for blood diseases, solid tumors, infectious diseases and lymphoma. Shanghai Rightongene Biotechnology Co., Ltd. was founded in 2012 and is based in Shanghai, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2012
Employees 385
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688217
Full Company Profile

Financial Performance

Financial Statements